BRASS Participants
Researchers and Collaborators

Recent Publications

  • Identification of smoking using Medicare data – a validation study of claims based algorithims.  Abstract»
  • Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concommitant fibromyalgia. Abstract»
  • Participation in clinical research registries: A focus group study examining views from patients with arthritis and other chronic illnesses. Abstract»
  • Effects of Achieving Target Measures in RA on Functional Status, Quality of Life and Resource Utilization: Analysis of Clinical Practice Data. Abstract»

The purpose of BRASS

The purpose of the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS), under the direction of Dr. Nancy Shadick and Dr. Michael Weinblatt, is to determine how genes can be used to predict whether Rheumatoid Arthritis (RA) will be mild or severe and to better understand how individuals respond to different drug treatments.
BRASS has over 1400 people diagnosed with RA who are patients at the Brigham & Women’s Hospital and who are followed in the clinic annually and sent questionnaires at six month intervals over a 15 year time span. Additionally, BRASS provides investigators with access to subsets of data as well as methodological support.

Find out more